FOSTER CITY, Calif. & WOBURN, Mass.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that it has signed a licensing and collaboration agreement with BioTrove, Inc. to commercialize an analysis platform for high-throughput genotyping applications. Applied Biosystems will develop and market custom-built arrays of TaqMan® SNP Genotyping Assays pre-loaded on BioTrove’s OpenArray™ platform. This platform will integrate the ease-of-use, accuracy, and reproducibility of Applied Biosystems’ TaqMan SNP Genotyping Assays with BioTrove’s flexible high-density assay format, enabling researchers to rapidly perform high-throughput genotyping studies at a lower total cost compared to alternative commercially available methods.
